Taiwan FDA registration ef40236cfaee1bd0b300c075777b8082

EASEmed Carcinoma embryonic Antigen (CEA) Rapid Test Kit

TW: 醫試美癌胚胎抗原快速檢驗試劑

Taiwan·Risk Class 2·MD·Kaiwu Technology Co., Ltd. Nanke Factory·Registered Jan 13, 2014 – Jan 13, 2029Active

Registration details

Analysis ID: ef40236cfaee1bd0b300c075777b8082
License Form: Ministry of Health Medical Device Manufacturing No. 004434

Company information

Manufacturer: Kaiwu Technology Co., Ltd. Nanke Factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Kaiwu Technology Co., Ltd. Nanke Factory

Product details

Intended Use: This product is a qualitative detection of carcinoembryonic antigen in human serum.
Product Type (Level 1): C Immunology and microbiology devices
Product Type (Level 2): C6010 Tumor-associated antigen immunoassay system
Import Information: Produced in Taiwan, China

Dates and status

Registration Date: Jan 13, 2014
Expiry Date: Jan 13, 2029

About this record

Access comprehensive regulatory information for EASEmed Carcinoma embryonic Antigen (CEA) Rapid Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ef40236cfaee1bd0b300c075777b8082 and manufactured by Kaiwu Technology Co., Ltd. Nanke Factory. The authorized representative in Taiwan is Kaiwu Technology Co., Ltd. Nanke Factory.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.